Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

127.01 +2.75 (+2.21%)
Streaming Delayed Price Updated: 12:38 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Glaukos Corporation Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Glaukos (GKOS) Q1 2026 Earnings Transcript ↗
Glaukos (GKOS) Q1 2026 Earnings Transcript 
Via The Motley Fool
Glaukos Corp (NYSE:GKOS) Shares Surge on Record Sales and Raised Guidance After Q1 Beat ↗
Via Chartmill
Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules ↗
Via Chartmill
News headline image
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
This biotech specializes in clinical-stage therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions. 
Via The Motley Fool
Topics Regulatory Compliance
Glaukos Corp (NYSE:GKOS) Reports Record 2025 Sales but Shares Dip on Wider Loss, Conservative Outlook ↗
Via Chartmill
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
Expert Outlook: Glaukos Through The Eyes Of 4 Analysts ↗
 
Via Benzinga
News headline image
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
Focused on retinal disease therapies, Kodiak Sciences leads with clinical-stage candidates targeting major unmet needs in ophthalmology. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
This UK-based biotech advances clinical-stage therapies for rare diseases, targeting specialty care markets with a diversified pipeline. 
Via The Motley Fool
News headline image
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients with limited treatment options. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
BrightSpring Health Services delivers integrated pharmacy and clinical care to Medicare, Medicaid, and insured patients nationwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos (GKOS) Q4 2025 Earnings Call Transcript ↗
Glaukos (GKOS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Director Sells GKOS 15,000 Shares for $1.9 Million ↗
This ophthalmic device maker, focused on glaucoma solutions, reported a notable insider sale after a challenging year for its stock. 
Via The Motley Fool
Topics Regulatory Compliance
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off ↗
Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Glaukos Stock Zoomed Almost 14% Higher on Thursday ↗
The company's recent past featured robust growth, and it anticipates continued rises into the near future. 
Via The Motley Fool
News headline image
Glaukos (GKOS) Q3 2025 Earnings Call Transcript ↗
Glaukos (GKOS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why Glaukos Stock Jumped Over 20% After-Hours Today ↗
Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance. 
Via Stocktwits
News headline image
What's going on in today's after hours session ↗
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
Glaukos Corp (NYSE:GKOS) Soars on Strong Q3 2025 Earnings Beat and Robust 2026 Outlook ↗
Glaukos (GKOS) smashed Q3 2025 earnings forecasts, sending its stock soaring. The company posted record revenue and raised its 2025 and 2026 sales guidance. 
Via Chartmill
Topics Earnings
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
 
Via Benzinga
News headline image
Expert Outlook: Glaukos Through The Eyes Of 7 Analysts ↗
 
Via Benzinga
News headline image
Glaukos (GKOS) Q2 Revenue Jumps 30% ↗
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.